A Study on the Relevance of Glucose-6-Phosphate Dehydrogenase Level Screening in Patients with Rheumatic Diseases Prior to Initiating Treatment With Hydroxychloroquine

Objective Drug-induced hemolytic anemia can occur in patients with glucose-6-phosphate-dehydrogenase (G6PD) deficiency. The practice of G6PD-deficiency screening in the rheumatology field has been inconsistent. This study aimed to determine the utility of screening prior to the initiation of hydroxy...

Descripción completa

Detalles Bibliográficos
Autores principales: Abramova, Irina, Park, Kyle, Hosny, Carol, Tuladhar, Swosty, Yao, QingPing, Patnaik, Asha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462653/
https://www.ncbi.nlm.nih.gov/pubmed/32884875
http://dx.doi.org/10.7759/cureus.9519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462653/
https://www.ncbi.nlm.nih.gov/pubmed/32884875
http://dx.doi.org/10.7759/cureus.9519

Ejemplares similares